蓝帆医疗冠脉冲击波系统获欧盟CE认证！华兰股份逆势上涨

Group 1 - The A-share market experienced fluctuations on January 20, with the medical device ETF (562600) showing a maximum decline of 0.76, while individual stocks like Hualan Biological (301093) and Bluestar Medical (002382) saw gains of 3.71% and 1.01% respectively [1] - The medical device ETF (562600) has attracted significant capital inflow, with a net inflow of 10.4 million yuan over the past five days and 24.3 million yuan over the past ten days [1] - Bluestar Medical announced that its subsidiary Biosensors received EU CE certification for the Lithonic coronary intravascular shockwave treatment system, enhancing the company's competitiveness in the cardiovascular field [1] Group 2 - The medical device industry is experiencing robust growth, and the medical device ETF (562600) provides a convenient way to capture growth opportunities, with a 23.8% allocation to brain-computer interface stocks, the highest among listed ETFs [2] - The medical device ETF (562600) has a high concentration in the medical device sector, accounting for 89.2%, effectively capturing growth opportunities in niche segments [2] - Investors can also consider alternative options such as the Huaxia CSI All-Index Medical Device ETF Initiated Link A (021250) and Huaxia CSI All-Index Medical Device ETF Initiated Link C (021251) for convenient investment [2]